Brief: Chromogenics Q2 EBITDA Loss SEK 10.2 Million
25/08/2023 07:41
Aug 25 (Reuters) - ChromoGenics AB CHRO.ST :
* Q2 NET SALES AMOUNTED TO SEK 3.8 (2.8) MILLION
* Q2 EBITDA AMOUNTED TO SEK -10.2 (-13.9) MILLION
Source text for Eikon: ID:nWkr7t0ynh
Further company coverage: CHRO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on ChromoGenics AB
See all newsBrief: Chromogenics Says Conditional Loan Of SEK 47.6 Mln Is Converted To Grant
Brief: Färna Invest Makes SEK 10/Shr Offer For Chromogenics
Brief: Chromogenics Q1 Pre-Tax Loss Widens To SEK 13.6 Mln
Brief: Chromogenics Gets First Order For North America
Brief: Chromogenics Initiates Cost Reduction Program